[DISCLOSURE]
Hanmi Pharmaceutical (128940) reported on Oct. 27 that its operating profit in the third quarter slumped 61.5 percent to 13.7 billion won (US$12.03 million) on-year.
The revenue fell 18.1 percent to 219.7 billion won and net profit turned to black at 6.3 billion won from the same period last year.
(
theinvestor@heraldcorp.com)
